Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Amphastar Pharmaceuticals Inc AMPH

Healthcare Drug Manufacturers - Specialty & Generic
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild... see more

Current News (NDAQ:AMPH)

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

ACCESS Newswire 12 days ago

Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference

ACCESS Newswire January 7, 2026

Amphastar Announces FDA Approval for Teriparatide Injection

ACCESS Newswire December 15, 2025

Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference

ACCESS Newswire November 24, 2025

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

ACCESS Newswire November 12, 2025

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025

ACCESS Newswire November 6, 2025

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025

ACCESS Newswire October 27, 2025

Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference

ACCESS Newswire August 28, 2025

Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.

ACCESS Newswire August 12, 2025
View More News ››

Opinion & Analysis (NDAQ:AMPH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:AMPH)

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) – A Dive

http://beyondspx.com/2024/07/31/amphastar-pharmaceuticals-inc-nasdaqamph-a-diversified-pharmaceutical-powerhouse-delivering-consistent...
MikeTester - August 2, 2024

AMPHASTAR: NEW FDA APPROVAL OPENS A FLOODGATE OF OPPORTUNITI

$AMPH Excited to share an article about Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a biopharmaceutical company focusing...
AviseAnalytics - March 13, 2023
View more Bullboard ››

Pinnacle Silver and Gold Corp

Pinnacle Silver and Gold Corp

Pinnacle Silver and Gold Corp., an exploration stage company, engages in the acquisition and exploration of mineral ...
View More »

Podcasts